The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Systematic literature review and indirect treatment comparisons (ITC) of glasdegib (GLAS) plus low dose ara-c (LDAC) versus a hypomethylating agent (HMA) for previously untreated acute myeloid leukemia (AML) patients ineligible for intensive chemotherapy (NIC).

Anna  Forsythe

Employment - Eisai

Consulting or Advisory Role - Bayer; Eisai; ImmunoGen; Novartis; Pfizer; Takeda

Bhakti  Arondekar

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Gabriel  Tremblay

No Relationships to Disclose

Geoffrey  Chan

Employment - Pfizer

Stock and Other Ownership Interests  - GlaxoSmithKline

Yun  Su

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer